Varian Medical Systems Stock Forecast, Price & News

Varian Medical Systems' stock was trading at $113.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, VAR shares have increased by 53.8% and is now trading at $173.90.
View which stocks have been most impacted by COVID-19.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 3 sell ratings, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Varian Medical Systems or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Varian Medical Systems a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Varian Medical Systems wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Varian Medical Systems is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for Varian Medical Systems.

Varian Medical Systems, Inc. (NYSE:VAR) issued its quarterly earnings data on Tuesday, October, 27th. The medical equipment provider reported $1.12 EPS for the quarter, beating the consensus estimate of $0.98 by $0.14. The medical equipment provider earned $850.50 million during the quarter, compared to analysts' expectations of $831.63 million. Varian Medical Systems had a return on equity of 19.68% and a net margin of 8.82%. During the same period last year, the business earned $1.21 EPS.
View Varian Medical Systems' earnings history.

9 equities research analysts have issued twelve-month price targets for Varian Medical Systems' stock. Their forecasts range from $90.00 to $178.00. On average, they expect Varian Medical Systems' stock price to reach $148.28 in the next year. This suggests that the stock has a possible downside of 14.7%.
View analysts' price targets for Varian Medical Systems.

Varian Medical Systems saw a drop in short interest in the month of October. As of October 30th, there was short interest totaling 2,210,000 shares, a drop of 58.1% from the October 15th total of 5,280,000 shares. Based on an average trading volume of 1,320,000 shares, the days-to-cover ratio is currently 1.7 days. Approximately 2.4% of the shares of the stock are short sold.
View Varian Medical Systems' Short Interest.

Some companies that are related to Varian Medical Systems include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD) and STERIS (STE).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Varian Medical Systems investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Laboratories (ABT), CVS Health (CVS), Gilead Sciences (GILD), Intel (INTC), Visa (V), The Coca-Cola (KO) and AbbVie (ABBV).

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

Varian Medical Systems' stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.06%), State Street Corp (4.38%), Carlson Capital L P (0.85%), UBS Asset Management Americas Inc. (0.72%), Assenagon Asset Management S.A. (0.65%) and BNP Paribas Arbitrage SA (0.52%). Company insiders that own Varian Medical Systems stock include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert and Timothy E Guertin.
View institutional ownership trends for Varian Medical Systems.

VAR stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, BlackRock Inc., Boston Trust Walden Corp, Congress Asset Management Co. MA, AXA S.A., State Street Corp, Charles Schwab Investment Management Inc., and New York State Common Retirement Fund. Company insiders that have sold Varian Medical Systems company stock in the last year include Christopher A Toth, Dow R Wilson, John W Kuo, Kolleen T Kennedy, Magnus Momsen, and R Andrew Eckert.
View insider buying and selling activity for Varian Medical Systems.

VAR stock was acquired by a variety of institutional investors in the last quarter, including Carlson Capital L P, Assenagon Asset Management S.A., ARP Americas LP, DLD Asset Management LP, TIG Advisors LLC, BNP Paribas Arbitrage SA, Alpine Associates Management Inc., and MUFG Securities EMEA plc.
View insider buying and selling activity for Varian Medical Systems.

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of VAR stock can currently be purchased for approximately $173.90.

Varian Medical Systems has a market capitalization of $15.81 billion and generates $3.23 billion in revenue each year. The medical equipment provider earns $291.90 million in net income (profit) each year or $4.63 on an earnings per share basis. Varian Medical Systems employs 10,062 workers across the globe.

The official website for Varian Medical Systems is www.varian.com.

Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]